Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2009, Article ID 738620, 8 pages
http://dx.doi.org/10.1155/2009/738620
Research Article

Leptin Induces an Inflammatory Phenotype in Lean Wistar Rats

Department of Molecular and Cellular Physiology, Louisiana State University Health Sciences Center, 1501 Kings Hwy, Shreveport, LA 71130, USA

Received 20 July 2009; Revised 29 September 2009; Accepted 15 October 2009

Academic Editor: Oreste Gualillo

Copyright © 2009 Monique Allman et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. Björntorp, “Body fat distribution, insulin resistance, and metabolic diseases,” Nutrition, vol. 13, no. 9, pp. 795–803, 1997. View at Publisher · View at Google Scholar · View at Scopus
  2. P. Björntorp, “Regional patterns of fat distribution,” Annals of Internal Medicine, vol. 103, no. 6, pp. 994–995, 1985. View at Google Scholar · View at Scopus
  3. C. Couillard, N. Bergeron, D. Prud'homme et al., “Gender difference in postprandial lipemia: importance of visceral adipose tissue accumulation,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 19, no. 10, pp. 2448–2455, 1999. View at Google Scholar · View at Scopus
  4. P. A. Kern, M. Saghizadeh, J. M. Ong, R. J. Bosch, R. Deem, and R. B. Simsolo, “The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase,” Journal of Clinical Investigation, vol. 95, no. 5, pp. 2111–2119, 1995. View at Google Scholar · View at Scopus
  5. P. A. Kern, S. Ranganathan, C. Li, L. Wood, and G. Ranganathan, “Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance,” American Journal of Physiology, vol. 280, no. 5, pp. E745–E751, 2001. View at Google Scholar · View at Scopus
  6. C. A. Curat, A. Miranville, C. Sengenès et al., “From blood monocytes to adipose tissue-resident macrophages: induction of diapedesis by human mature adipocytes,” Diabetes, vol. 53, no. 5, pp. 1285–1292, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. V. Nobili, M. Manco, P. Ciampalini et al., “Leptin, free leptin index, insulin resistance and liver fibrosis in children with non-alcoholic fatty liver disease,” European Journal of Endocrinology, vol. 155, no. 5, pp. 735–743, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  8. Y. Benomar, S. Wetzler, C. Larue-Achagiotis, J. Djiane, D. Tomé, and M. Taouis, “In vivo leptin infusion impairs insulin and leptin signalling in liver and hypothalamus,” Molecular and Cellular Endocrinology, vol. 242, no. 1-2, pp. 59–66, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  9. K. Ikejima, H. Honda, M. Yoshikawa et al., “Leptin augments inflammatory and profibrogenic responses in the murine liver induced by hepatotoxic chemicals,” Hepatology, vol. 34, no. 2, pp. 288–297, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  10. G. Singer, J. Houghton, C. A. Rivera, C. Anthoni, and D. N. Granger, “Role of LPS in the hepatic microvascular dysfunction elicited by cecal ligation and puncture in mice,” Journal of Hepatology, vol. 47, no. 6, pp. 799–806, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  11. C. A. Rivera, S. H. Abrams, M. H. Tcharmtchi et al., “Feeding a corn oil/sucrose-enriched diet enhances steatohepatitis in sedentary rats,” American Journal of Physiology, vol. 290, no. 2, pp. G386–G393, 2006. View at Publisher · View at Google Scholar · View at PubMed
  12. R. V. Considine, M. K. Sinha, M. L. Heiman et al., “Serum immunoreactive-leptin concentrations in normal-weight and obese humans,” New England Journal of Medicine, vol. 334, no. 5, pp. 292–295, 1996. View at Publisher · View at Google Scholar · View at Scopus
  13. G. Fantuzzi and R. Faggioni, “Leptin in the regulation of immunity, inflammation, and hematopoiesis,” Journal of Leukocyte Biology, vol. 68, no. 4, pp. 437–446, 2000. View at Google Scholar · View at Scopus
  14. G. Matarese, C. Procaccini, and V. De Rosa, “The intricate interface between immune and metabolic regulation: a role for leptin in the pathogenesis of multiple sclerosis?” Journal of Leukocyte Biology, vol. 84, no. 4, pp. 893–899, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  15. G. Matarese, A. Di Giacomo, V. Sanna et al., “Requirement for leptin in the induction and progression of autoimmune encephalomyelitis,” Journal of Immunology, vol. 166, no. 10, pp. 5909–5916, 2001. View at Google Scholar · View at Scopus
  16. G. Matarese, P. B. Carrieri, A. La Cava et al., “Leptin increase in multiple sclerosis associates with reduced number of CD4+CD25+ regulatory T cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 14, pp. 5150–5155, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  17. A. La Cava and G. Matarese, “The weight of leptin in immunity,” Nature Reviews Immunology, vol. 4, no. 5, pp. 371–379, 2004. View at Google Scholar · View at Scopus
  18. A. Valeric, M. Dossena, P. Bertolotti et al., “Leptin is induced in the ischemic cerebral cortex and exerts neuroprotection through NF-κB/c-Rel-dependent transcription,” Stroke, vol. 40, no. 2, pp. 610–617, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  19. G. D. Norata, S. Raselli, L. Grigore et al., “Leptin:adiponectin ratio is an independent predictor of intima media thickness of the common carotid artery,” Stroke, vol. 38, no. 10, pp. 2844–2846, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  20. O. Ukkola, S. Poykko, M. Paivansalo, and Y. A. Kesaniemi, “Interactions between ghrelin, leptin and IGF-I affect metabolic syndrome and early atherosclerosis,” Annals of Medicine, vol. 40, no. 6, pp. 465–473, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  21. P. Kougias, H. Chai, P. H. Lin, Q. Yao, A. B. Lumsden, and C. Chen, “Effects of adipocyte-derived cytokines on endothelial functions: implication of vascular disease,” Journal of Surgical Research, vol. 126, no. 1, pp. 121–129, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  22. S. Terao, G. Yilmaz, K. Y. Stokes, M. Ishikawa, T. Kawase, and D. N. Granger, “Inflammatory and injury responses to ischemic stroke in obese mice,” Stroke, vol. 39, no. 3, pp. 943–950, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  23. G. Tarantino, G. Saldalamacchia, P. Conca, and A. Arena, “Non-alcoholic fatty liver disease: further expression of the metabolic syndrome,” Journal of Gastroenterology and Hepatology, vol. 22, no. 3, pp. 293–303, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  24. F. Harnois, S. Msika, J.-M. Sabaté et al., “Prevalence and predictive factors of non-alcoholic steatohepatitis (NASH) in morbidly obese patients undergoing bariatric surgery,” Obesity Surgery, vol. 16, no. 2, pp. 183–188, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  25. J. P. Ong, H. Elariny, R. Collantes et al., “Predictors of nonalcoholic steatohepatitis and advanced fibrosis in morbidly obese patients,” Obesity Surgery, vol. 15, no. 3, pp. 310–315, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  26. M. Kroh, R. Liu, and B. Chand, “Laparoscopic bariatric surgery: what else are we uncovering? Liver pathology and preoperative indicators of advanced liver disease in morbidly obese patients,” Surgical Endoscopy, vol. 21, no. 11, pp. 1957–1960, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  27. K. Ikejima, Y. Takei, H. Honda et al., “Leptin receptor-mediated signaling regulates hepatic fibrogenesis and remodeling of extracellular matrix in the rat,” Gastroenterology, vol. 122, no. 5, pp. 1399–1410, 2002. View at Google Scholar · View at Scopus
  28. N. K. Saxena, K. Ikeda, D. C. Rockey, S. L. Friedman, and F. A. Anania, “Leptin in hepatic fibrosis: evidence for increased collagen production in stellate cells and lean littermates of ob/ob mice,” Hepatology, vol. 35, no. 4, pp. 762–771, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  29. H. Honda, K. Ikejima, M. Hirose et al., “Leptin is required for fibrogenic responses induced by thioacetamide in the murine liver,” Hepatology, vol. 36, no. 1, pp. 12–21, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  30. S. Q. Yang, H. Z. Lin, M. D. Lane, M. Clemens, and A. M. Diehl, “Obesity increases sensitivity to endotoxin liver injury: implications for the pathogenesis of steatohepatitis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 94, no. 6, pp. 2557–2562, 1997. View at Publisher · View at Google Scholar · View at Scopus
  31. M. Argentou, D. G. Tiniakos, M. Karanikolas et al., “Adipokine serum levels are related to liver histology in severely obese patients undergoing bariatric surgery,” Obesity Surgery, vol. 19, no. 9, pp. 1313–1323, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  32. L. E. Muñoz, P. Cordero, L. Torres, A. Y. Sauceda, J. P. Flores, and J. J. Segura, “Adipokines in a group of mexican patients with nonalcoholic steatohepatitis,” Annals of Hepatology, vol. 8, no. 2, pp. 123–128, 2009. View at Google Scholar · View at Scopus
  33. M. Lemoine, V. Ratziu, M. Kim et al., “Serum adipokine levels predictive of liver injury in non-alcoholic fatty liver disease,” Liver International, vol. 29, no. 9, pp. 1431–1438, 2009. View at Google Scholar · View at Scopus
  34. Y. Kamada, H. Matsumoto, S. Tamura et al., “Hypoadiponectinemia accelerates hepatic tumor formation in a nonalcoholic steatohepatitis mouse model,” Journal of Hepatology, vol. 47, no. 4, pp. 556–564, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  35. J. Fukushima, Y. Kamada, H. Matsumoto et al., “Adiponectin prevents progression of steatohepatitis in mice by regulating oxidative stress and Kupffer cell phenotype polarization,” Hepatology Research, vol. 39, no. 7, pp. 724–738, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  36. F. Zhang, S. Wang, A. P. Signore, and J. Chen, “Neuroprotective effects of leptin against ischemic injury induced by oxygen-glucose deprivation and transient cerebral ischemia,” Stroke, vol. 38, no. 8, pp. 2329–2336, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  37. K. L. Palamara, H. R. Mogul, S. J. Peterson, and W. H. Frishman, “Obesity: new perspectives and pharmacotherapies,” Cardiology in Review, vol. 14, no. 5, pp. 238–258, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus